NM107

产品说明书

Print
Chemical Structure| 20724-73-6 同义名 : 2'-C-Methylcytidine; 2CMC; mCyd; 2'-C-MeC
CAS号 : 20724-73-6
货号 : A147052
分子式 : C10H15N3O5
纯度 : 98%
分子量 : 257.24
MDL号 : MFCD02682947
存储条件:

Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 : -
动物实验配方:
生物活性
描述 Hepatitis C virus (HCV) is a 9.6-kb positive-sense, single-stranded RNA virus. The NS5B RNA-dependent RNA polymerase has enzymatic activity essential for viral replication. NM107 is a nucleoside HCV NS5B polymerase inhibitor. In HCV replicon cells (Huh-luc/neo-ET), treatment with NM107 for 48 h resulted in a concentration-dependent inhibition of HCV replication, the EC50 and CC50 were 0.48 and > 100 μM, respectively. The combination of 2 μM NM107 and 0.5 μM NIM811 (a host cyclophilin inhibitor) led to a 2.1-log reduction. Furthermore, the combination of 0.5 μM NIM811 and 5 μM NM107 resulted in a 3.1-log HCV RNA reduction, which was much better than either used alone[3]. In Huh7 cultures, treatment of infected cells with 25 μM NM107 for 24 h resulted in an intracellular HCV RNA decline, consistent with NM107 blocking HCV replication. Moreover, extracellular virus titers declined in parallel with intracellular RNA levels as expected[4].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

3.89mL

0.78mL

0.39mL

19.44mL

3.89mL

1.94mL

38.87mL

7.77mL

3.89mL

参考文献

[1]Guedj J, Dahari H, et al. Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3991-6.

[2]McCown MF, Rajyaguru S, et al. The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogs than to nonnucleosidepolymerase or protease inhibitors. Antimicrob Agents Chemother. 2008 May;52(5):1604-1612.

[3]Mathy JE, Ma S, Compton T, Lin K. Combinations of cyclophilin inhibitor NIM811 with hepatitis C Virus NS3-4A Protease or NS5B polymerase inhibitors enhance antiviral activity and suppress the emergence of resistance. Antimicrob Agents Chemother. 2008 Sep;52(9):3267-75

[4]Guedj J, Dahari H, Rong L, et, al. Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3991-6